PAVmed Inc. (PAVM) financial statements (2021 and earlier)

Company profile

Business Address ONE GRAND CENTRAL PLACE
NEW YORK, NY 10165
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 8,2221,535586
Cash and cash equivalents 8,2221,535586
Prepaid expense  74107
Other undisclosed current assets 2381448
Total current assets: 8,4601,623741
Noncurrent Assets
Property, plant and equipment 361618
Other undisclosed noncurrent assets   111
Total noncurrent assets: 3616129
TOTAL ASSETS: 8,4961,640870
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3,0701,5701,189
Accounts payable 1,739864949
Accrued liabilities 1,331706240
Debt 7,903  
Other undisclosed current liabilities  973 
Total current liabilities: 10,9732,5441,189
Noncurrent Liabilities
Long-term debt and lease obligation  1,944 
Long-term debt, excluding current maturities  1,944 
Total noncurrent liabilities:  1,944 
Total liabilities: 10,9734,4881,189
Stockholders' equity
Stockholders' equity attributable to parent, including: (2,315)(2,848)(319)
Common stock 271513
Additional paid in capital 32,61914,0127,369
Accumulated deficit (36,993)(17,908)(7,702)
Other undisclosed stockholders' equity attributable to parent 2,0321,033 
Stockholders' equity attributable to noncontrolling interest (162)  
Total stockholders' equity: (2,476)(2,848)(319)
TOTAL LIABILITIES AND EQUITY: 8,4961,640870

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Operating expenses (10,563)(8,034)(5,651)
Operating loss: (10,563)(8,034)(5,651)
Nonoperating expense
(Other Nonoperating expense)
 (7,610)(1,485) 
Interest and debt expense (615)(725) 
Other undisclosed income from continuing operations before equity method investments, income taxes 615725 
Loss from continuing operations before income taxes: (18,173)(9,519)(5,651)
Income tax benefit  577 
Loss before gain (loss) on sale of properties: (18,173)(8,943)(5,651)
Other undisclosed net income 18,377  
Net income (loss): 204(8,943)(5,651)
Net income attributable to noncontrolling interest 204  
Other undisclosed net loss attributable to parent (18,377)(577) 
Net loss attributable to parent: (17,969)(9,519)(5,651)
Preferred stock dividends and other adjustments (26)(113) 
Other undisclosed net loss available to common stockholders, basic (756)(766) 
Net loss available to common stockholders, diluted: (18,751)(10,398)(5,651)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Net income (loss): 204(8,943)(5,651)
Comprehensive income (loss): 204(8,943)(5,651)
Comprehensive income, net of tax, attributable to noncontrolling interest 204  
Comprehensive income (loss), net of tax, attributable to parent: 408(8,943)(5,651)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: